In the Matter of the Child of: M. E. P. and T. H. V., Parents

Court of Appeals of Minnesota·Decided February 26, 2024·No. a231176·Published

Opinion

STATE OF MINNESOTA

IN COURT OF APPEALS

A23-1176

In the Matter of the Child of: M. E. P. and T. H. V., Parents.

Filed February 26, 2024

Affirmed

Johnson, Judge

Wright County District Court File No. 86-JV-23-591

Lucas J.M. Dawson, Christina Zauhar, Halberg Criminal Defense, Bloomington, Minnesota (for appellant parents)

Brian A. Lutes, Wright County Attorney, Lindsey R. Danielson, Assistant County Attorney, Buffalo, Minnesota (for respondent Wright County Health and Human Services)

John Jerabek, Tuft, Lach, Jerabek & O’Connell, Maplewood, Minnesota (for guardian ad litem)

Considered and decided by Johnson, Presiding Judge; Segal, Chief Judge; and Cochran, Judge.

SYLLABUS

1. The district court did not err by determining that a five-year-old child with an aggressive form of cancer is in need of protection or services because his parents had rejected a physician’s recommendation that the child continue to receive a chemotherapy treatment that is widely accepted for the child’s type of cancer and likely is necessary for the child’s survival.

2. The district court’s order requiring chemotherapy treatment for a five-year-

old child with an aggressive form of cancer, over his parents’ objection, does not violate the parents’ constitutional rights to the care, custody, and control of their child in light of

the district court’s findings that the chemotherapy treatment is well accepted in the medical community and that the child’s probability of survival is more than 90 percent with the treatment and less than 20 percent without the treatment.

OPINION

JOHNSON, Judge When K.K.P. was four years old, he was diagnosed with leukemia. He began a five-

phase chemotherapy treatment, which has a survival rate of more than 90 percent, as compared to a survival rate of less than 20 percent without the treatment. K.K.P.’s parents decided to discontinue chemotherapy after he had completed the first phase of the treatment. Wright County petitioned the district court for an order adjudicating K.K.P. a child in need of protection or services and an order requiring the continuation of chemotherapy. Following an emergency protective-care hearing, the district court granted interim legal custody of K.K.P. to the county, placed him in foster care with a relative, and ordered that he continue to receive the recommended chemotherapy. Later, after a four- day trial, the district court granted the county’s petition and reiterated its prior orders. K.K.P.’s parents appeal. We conclude that the district court did not err by adjudicating K.K.P. a child in need of protection or services or by ordering an out-of-home placement. We also conclude that the district court’s orders requiring chemotherapy do not violate the parents’ constitutional rights to the care, custody, and control of their child. Therefore, we affirm.

FACTS

K.K.P. is now six years old. Before the events that precipitated this action, he lived with his mother, M.E.P., his father, T.H.V., and a younger brother, traveling as necessary for T.H.V.’s work in the oil-and-gas industry in Texas, Oklahoma, and nearby states.

In December 2022, K.K.P. and his family traveled to Wright County, Minnesota to visit relatives who reside there. On December 16, K.K.P.’s mother took him to a pediatrician because he had been ill for three weeks and she had observed swollen lymph nodes and a rash on his body. The pediatrician performed a blood test, which indicated a dangerously high white-blood-cell count. While in the pediatrician’s examination room, K.K.P. became “really sleepy” and “couldn’t stay awake.” K.K.P. went to Children’s Hospital in Minneapolis by ambulance.

At Children’s Hospital, K.K.P. was diagnosed as having had a hemorrhagic stroke.

He was admitted to the pediatric intensive care unit (PICU). Soon thereafter, he was diagnosed with T-Cell Acute Lymphoblastic Leukemia (T-Cell ALL), an aggressive form of cancer that likely results in death if left untreated. While in the PICU, K.K.P. underwent leukapheresis, a procedure that filters and removes white blood cells from the body, and he was given a steroid to reduce swelling in and around his brain.

K.K.P.’s treatment was overseen by Nathan Gossai, M.D., a physician with expertise in T-Cell ALL and the director of the leukemia and lymphoma program at Children’s Hospital. Dr. Gossai recommended a chemotherapy treatment protocol that is associated with a 93 percent chance of survival, which K.K.P.’s parents initially approved.

As explained by Dr. Gossai at trial, the chemotherapy protocol for T-Cell ALL consists of five phases. The first phase, induction, is intended to “quickly and efficiently . . . remove the leukemia from the peripheral bloodstream, and ideally from the bone marrow,” so that the leukemia no longer is detectable. The cancer is considered not detectable if 0.02 percent or fewer of the 500,000 white blood cells in a tested sample indicate the presence of the disease. Because there are billions of white blood cells in a human body, a determination that cancer is not detectable does not mean that cancer is not present in a patient’s body.

The second phase of the chemotherapy treatment recommended by Dr. Gossai, consolidation, uses various medications to keep residual leukemia in the blood and bone marrow “at bay,” while focusing on treating the spinal fluid through “four consecutive weekly lumbar punctures, that include the administration of chemotherapy.” The third phase, interim maintenance, involves the intravenous administration of medication to treat the blood, bone marrow, and cerebrospinal fluid. The fourth phase, delayed intensification, is intended “to continue to stay ahead of a potentially evolving leukemia while treating leukemia that may well be undetectable,” by utilizing “different medications on different structures, timeframes, and methodologies.” The fifth and final phase, maintenance, involves oral medications given at home, intravenous medication once per month, and chemotherapy delivered via lumbar puncture once every three months.

K.K.P. began the T-Cell ALL chemotherapy treatment protocol on December 20, 2022. He was discharged from the hospital on January 10, 2023, and he completed the first phase of treatment at a Children’s Hospital clinic soon thereafter. K.K.P. experienced

numerous side effects during the first phase of treatment, including fatigue, poor appetite, nausea, vomiting, muscle weakness (myopathy), short-term neuropathy, and irritation of the bladder (cystitis).

K.K.P. was scheduled to begin the second phase of chemotherapy treatment on January 23, 2023. But he did not begin the second phase on that date because his parents objected based on concerns about the efficacy of the treatment and the severity of its side effects. K.K.P.’s mother expressed a preference for natural remedies, and she consulted with a naturopathic doctor, Helen Healy, N.D., 1 with whom she discussed herbs and supplements that might be used to treat K.K.P. K.K.P.’s mother discussed potential alternative therapies with Dr. Gossai, such as the use of garlic and lemon. Dr. Gossai engaged in ongoing discussions with K.K.P.’s parents about the necessity of chemotherapy treatment. He discussed “the risks and benefits of therapy,” including potential side effects. He informed K.K.P.’s parents that “undertreated T-Cell disease is nearly impossible to cure and would be likely to lead to [K.K.P.’s] death.” He also arranged for the parents to receive a second opinion by a Texas physician, who recommended the same course of treatment. Dr. Gossai gave the parents a few days to consider the matter, but they elected to discontinue the recommended chemotherapy treatment in favor of alternative remedies.

Free access — add to your briefcase to read the full text and ask questions with AI

In the Matter of the Child of: M. E. P. and T. H. V., Parents, (Mich. Ct. App. 2024).

In the Matter of the Child of: M. E. P. and T. H. V., Parents (In the Matter of the Child of: M. E. P. and T. H. V., Parents) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Parham v. J. R.
442 U.S. 584 (Supreme Court, 1979)
Troxel v. Granville
530 U.S. 57 (Supreme Court, 2000)
State, Department of Human Services v. Hamilton
657 S.W.2d 425 (Court of Appeals of Tennessee, 1983)
Thiele v. Stich
425 N.W.2d 580 (Supreme Court of Minnesota, 1988)
In Re Custody of NAK
649 N.W.2d 166 (Supreme Court of Minnesota, 2002)
Custody of a Minor
379 N.E.2d 1053 (Massachusetts Supreme Judicial Court, 1978)
In Re the Welfare of the Children of S.E.P.
744 N.W.2d 381 (Supreme Court of Minnesota, 2008)
Soohoo v. Johnson
731 N.W.2d 815 (Supreme Court of Minnesota, 2007)
Newmark v. Williams
588 A.2d 1108 (Supreme Court of Delaware, 1991)
In Re Welfare of Doege
240 N.W.2d 562 (Supreme Court of Minnesota, 1976)
In Re Willmann
493 N.E.2d 1380 (Ohio Court of Appeals, 1986)
Jason S. v. Valley Hospital Medical Center
87 P.3d 521 (Nevada Supreme Court, 2004)